Immunologically Active Peptides Capable Of Inducing Immunization Against Malaria And Genes Encoding Therefor

Type
Compound(s)

An immunologically active substantially pure peptide capable of inducing in human an immune response which is cross reactive with and protective against infection by a malaria parasite, wherein the peptide contains at least 2 consecutive repeats of a sequence Asn-X-Y-Pro wherein X is Ala or Val and Y is Asn or Asp or a sequence of the formula Thr-Glu-Trp-Z-Pro-Cys-Ser-Val-Thr-Cys-Gly-Asn-Gly wherein Z is Ser or Thr or the formula Lys-Pro-S-T-S-Lys-Leu-Lys-Gln-Pro-U-V-Gly-W-Pro wherein S is Lys or Asn, T is His or Glu, U is Gly or Asn, V is As or Glu, and W is Asn or Gln is disclosed along with DNA sequences and various other genetic materials useful in producing these peptides through biological methods.

Disease
Malaria
Research areas
Basic research
Vaccine
Condition of use

n/a

IP information

Granted Patent Reference Number(s): US, , Patent No. 4,707,357, Issued 17 Nov 1987; HHS, Reference No. E-553-1984/0; Expired